Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  January 6, 2026
Memoranda
2026 Forecast for U.S. Federal and International Chemical Regulatory Policy

Download a PDF of the Forecast 2026. Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia...

  December 29, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  January 7, 2026
Memoranda
EPA Publishes Final Risk Evaluation for 1,3-Butadiene, Intends to Regulate 11 COUs to Protect Workers

The U.S. Environmental Protection Agency (EPA) announced on January 5, 2026, the availability of the final risk evaluation under the Toxic Substances...

  December 16, 2025
Memoranda
Cracks in the Enamel: The Ascendance of Federal and State Action to Restrict Fluoride Use 

Fluoride, well-known for its anticavity properties, has seen a growing number of state and federal initiatives seeking to limit or prohibit various...

  December 8, 2025
Memoranda
EPA Begins Public Comment Period on Updated Draft Risk Calculation Memorandum for Formaldehyde

On December 3, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and solicited public comment on an Updated Draft...

  December 5, 2025
Memoranda
European Union Deforestation Regulation Faces Likely Delay

The European Union Deforestation Regulation (EUDR) appears to be headed for yet another full-year delay following growing political pressure, concerns...

Seminars & Webinars

  January 5, 2026
Seminars & Webinars
What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2026, January 27, 2026, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Register now to join The Acta Group (Acta®) and Bergeson & Campbell, P.C. (B&C®) for “What to Expect in Chemicals Policy and Regulation...

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

  November 6, 2025
Seminars & Webinars
Environmental Law 2026, February 19-20, 2026, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2026,” a two-day program on the latest developments across every major area of environmental law—from air,...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.’s. Government affairs and regulatory specialists including four high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.